← Back to Search

Implementation Intervention for Cerebral Palsy

N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Licensed to practice physical or occupational therapy in Canada.
2. Report that CP comprises ≥20% of their caseload over the past year.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months post-intervention
Awards & highlights
No Placebo-Only Group

Summary

Physical rehabilitation interventions that promote activity-dependent neuroplasticity are desired for children with CP as this will result in improved motor skill and function. In adult neurological populations, such as stroke and spinal cord injury, FES is a recommended, evidence-based intervention that addresses motor and sensory impairments and promotes neuroplasticity (Milosevic et al. 2020). The evidence base supporting the safety, feasibility and efficacy of FES for youth with CP is rapidly growing (Novak et al. 2020, Lee et al. 2020), yet FES is not commonly used in Canadian pediatric rehabilitation (Auchstaetter et al. 2016). Through interviews with Canadian pediatric physical and occupational therapists, we identified numerous barriers to FES implementation, including a lack of knowledge and training in FES, difficulty accessing FES equipment, and a perceived lack of time to deliver FES within a treatment session (Musselman et al. 2023). To address these barriers, we have developed an implementation intervention for FES that consists of an online course and toolkit for physical and occupational therapists. As a next step, we will evaluate the effects of the implementation intervention on pediatric therapists' knowledge, confidence and use of FES.

Eligible Conditions
  • Cerebral Palsy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Semi-structured Interview

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Implementation InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,523 Previous Clinical Trials
503,324 Total Patients Enrolled
1 Trials studying Cerebral Palsy
10 Patients Enrolled for Cerebral Palsy
~12 spots leftby May 2025